P Mathieu, J C Charvet, G Chazot, P Trouillas. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AnimalsAzo CompoundsBrain ChemistryCaudate Nucleus/analysisCerebral Cortex/analysisChromatography, PaperDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/therapeutic useHallucinations/cerebrospinal fluidHallucinations/chemically inducedHumansHypothalamus/analysisMethodsParkinson Disease/cerebrospinal fluidPhenylacetates/analysisPhenylacetates/cerebrospinal fluidPhenylacetates/urinePsychoses, Substance-InducedPsychotic Disorders/cerebrospinal fluidSchizophrenia/cerebrospinal fluidSchizophrenia/drug therapySheep
Substances: See more » Azo CompoundsPhenylacetatesDihydroxyphenylalanine
Year: 1972 PMID: 4645252 DOI: 10.1016/0009-8981(72)90490-1
Source DB: PubMed Journal: Clin Chim Acta ISSN: 0009-8981 Impact factor: 3.786